One of the most prominent issues of the 21st century is how to make healthcare more accessible, and the pandemic is arguably the tipping point. While it exposed the consequences of continued fragmentation, inequities and the rising costs of healthcare, it also demonstrated how it’s possible to make healthcare accessible to everyone, everywhere. In this episode, we look at how to expand this accessibility going forward by rethinking the patient journey and the role of health technology.
A conversation with Claire Kane, EVP and Director of Strategic Planning at Wunderman Thompson Health., moderated by Seth Duncan of Real Chemistry and Marjorie Reedy of Merck (Co-Chairs of the Pharma Council)
One of the most prominent issues of the 21st century is how to make healthcare more accessible, and the pandemic is arguably the tipping point. While it exposed the consequences of continued fragmentation, inequities and the rising costs of healthcare, it also demonstrated how it’s possible to make healthcare accessible to everyone, everywhere. In this episode, we look at how to expand this accessibility going forward by rethinking the patient journey and the role of health technology.
A conversation with Claire Kane, EVP and Director of Strategic Planning at Wunderman Thompson Health., moderated by Seth Duncan of Real Chemistry and Marjorie Reedy of Merck (Co-Chairs of the Pharma Council)